Septicemia, access and cardiovascular disease in dialysis patients: The USRDS Wave 2 Study

Kidney International

Volumn 68, Issue 1, 2005, Pages 311-318

  Ishani, Areef ^a   Collins, Allan J ^b   Herzog, Charles A ^b   Foley, Robert N ^b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b NONE

Author keywords

Bacteremia; Cardiovascular disease; Death; Septicemia; Vascular access

Indexed keywords

ADULT; AGED; ARTICLE; BACTEREMIA; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CATHETER; CAUSE OF DEATH; COMORBIDITY; CONTROLLED STUDY; FEMALE; HAZARD ASSESSMENT; HEART FAILURE; HEART INFARCTION; HEMODIALYSIS PATIENT; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MEDICARE; MORBIDITY; MORTALITY; PERIPHERAL VASCULAR DISEASE; PERITONEAL DIALYSIS; PRIORITY JOURNAL; REGRESSION ANALYSIS; SEPTICEMIA; VASCULAR ACCESS; CHRONIC KIDNEY FAILURE; CONGESTIVE HEART FAILURE; MIDDLE AGED; PREVALENCE; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; RENAL REPLACEMENT THERAPY; STATISTICS; UNITED STATES;

ADULT; AGED; BACTEREMIA; COMORBIDITY; FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; INCIDENCE; KIDNEY FAILURE, CHRONIC; MALE; MEDICARE; MIDDLE AGED; MYOCARDIAL INFARCTION; PREVALENCE; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RENAL DIALYSIS; UNITED STATES;

EID: 24944439987     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1111/j.1523-1755.2005.00414.x     Document Type: Article

References (49)

1. LIBBY P, RIDKER PM, MASERI A: Inflammation and atherosclerosis. Circulation 105:1135-1143, 2002
2. U.S. RENAL DATA SYSTEM: USRDS 1998 Annual Data Report: Atlas of End-Stage Renal Disease in the United States, Bethesda, MD, 1998
3. US.RENAL DATA SYSTEM: USRDS 2002 Annual Data Report: Atlas of End-Stage Renal Disease in the United States. Bethesda, MD, 2002
4. CHEUNG AK, SARNAK MJ, YAN G, et al: Atherosclerotic cardiovascular disease risks in chronic hemodialysis patients. Kidney Int 58:353-362, 2000
5. ZIMMERMANN J, HERRLINGER S, PRUY A, et al: Inflammation enhances cardiovascular risk and mortality in hemodialysis patients. Kidney Int 55:648-658, 1999
6. NOH H, LEE SW, KANG SW, et al: Serum C-reactive protein: A predictor of mortality in continuous ambulatory peritoneal dialysis patients. Perit Dial Int 18:387-394, 1998
7. POWE NR, JAAR B, FURTH SL, et al: Septicemia in dialysis patients: Incidence, risk factors, and prognosis. Kidney Int 55:1081-1090, 1999
8. NASSAR GM, AYUS JC: Infectious complications of the hemodialysis access. Kidney Int 60:1-13, 2001
9. AYUS JC, SHEIKH-HAMAD D: Silent infection in clotted hemodialysis access grafts. J Am Soc Nephrol 9:1314-1317, 1998
10. UNITED STATES RENAL DATA SYSTEM: United States Renal Data System. Researcher's Guide to the USRDS Database. Bethesda, MD, 2003
11. UNITED STATES RENAL DATA SYSTEM: USRDS 2002 Annual Data Report: Atlas of End-Stage Renal Disease in the United States, Bethesda, MD, National Institute of Diabetes and Digestive and Kidney Diseases, 2000
12. SARNAK MJ, JABER BL: Mortality caused by sepsis in patients with end-stage renal disease compared with the general population. Kidney Int 58:1758-64, 2000
13. BLOEMBERGEN WE, STANNARD DC, PORT FK, et al: Relationship of dose of hemodialysis and cause-specific mortality. Kidney Int 50:557-565, 1996
14. UNITED STATES RENAL DATA SYSTEM: USRDS 2000 Annual Data Report: Atlas of End-Stage Renal Disease in the United States, Bethesda, MD, National Institute of Diabetes and Digestive and Kidney Diseases, 2000
15. DI IORIO B, LOPEZ T, PROCIDA M, et al: Successful use of central venous catheter as permanent hemodialysis access: 84-month follow-up in lucania. Blood Purif 19:39-43, 2001
16. MCLAUGHLIN K, JONES B, MACTIER R, PORTEUS C: Long-term vascular access for hemodialysis using silicon dual-lumen catheters with guidewire replacement of catheters for technique salvage. Am J Kidney Dis 29:553-559, 1997
17. DI IORIO BR, BELLIZZI V, CILLO N, et al: Vascular access for hemodialysis: The impact on morbidity and mortality. J Nephrol 17:19-25, 2004
18. ABBOTT KC, NAPIER MG, AGODOA LY: Hospitalizations for bacterial speticemia in patients with end stage renal disease due to diabetes on the renal transplant waiting list. J Nephrol 15:248-254, 2002
19. D'AGATA EM, MOUNT DB, THAYER V, SCHAFFNER W: Hospital-acquired infections among chronic hemodialysis patients. Am J Kidney Dis 35:1083-1088, 2000
20. LIU JW, SU YK, LIU CF, CHEN JB: Nosocomial blood-stream infection in patients with end-stage renal disease: Excess length of hospital stay, extra cost and attributable mortality. J Hosp Infect 50:224-227, 2002
21. SAXENA AK, PANHOTRA BR, NAGUIB M, et al: Outcome of dialysis access-related septicemia among diabetics following optimized AV-fistula placement. Kidney Blood Press Res 25:109-114, 2002
22. SAXENA AK, PANHOTRA BR, VENKATESHAPPA CK, et al: The impact of nasal carriage of methicillin-resistant and methicillin-susceptible Staphylococcus a ureus (MRSA & MSSA) on vascular access-related speticemia among patients with type-II diabetes on dialysis. Ren Fail 30:288-295, 2002
23. STEVENSON KB, HANNAH EL, LOWDER CA, et al: Epidemiology of hemodialysis vascular access infections from longitudinal infection surveillance data: Predicting the impact of NKF-DOQI clinical practice guidelines for vascular access. Am J Kidney Dis 39:549-555, 2002
24. TOKARS JI, LIGHT P, ANDERSON J, et al: Prospective study of vascular access infections at seven outpatient hemodialysis centers. Am J Kidney Dis 37:1232-1240, 2001
25. TOKARS JI, MILLER ER, STEIN G: New national surveillance system for hemodialysis-associated infections: Initial results. Am J Infect Control 30:288-295, 2002
26. DHINGRA RK, YOUNG EW, HULBERT-SHEARON TE, et al: Type of vascular access and mortality in U.S. hemodialysis patients. Kidney Int 60:1443-1451, 2001
27. PASTAN S, SOUCIE JM, MCCLELLAN WM: Vascular access and increased risk of death among hemodialysis patients. Kidney Int 62:620-626, 2002
28. SMEETH L, THOMAS SL, HALL AJ, et al: Risk of myocardial infarction and stroke after acute infection or vaccination. N Engl J Med 351:2611-2618, 2004
29. HOTCHKISS RS, KARL IE: The pathophysiology and treatment of sepsis. N Engl J Med 348:138-150, 2003
30. RAAD I, COSTERTON W, SABHARWAL U, et al: Ultrastructural analysis of indwelling vascular catheters: A quantitative relationship between luminal colonization and duration of placement. J Infect Dis 168:400-407, 1993
31. RAAD I: Intravascular-catheter-related infections. Lancet 351:893-898, 1998
32. RAHMATI MA, CRAIG RG, HOMEL P, et al: Serum markers of periodontal disease status and inflammation in hemodialysis patients. Am J Kidney Dis 40:983-989, 2002
33. LIBBY P, RIDKER PM, MASERI A: Inflammation and atherosclerosis. Circulation 105:1135-1143, 2002
34. ZHU J, QUYYUMI AA, NORMAN JE, et al: Effects of total pathogen burden on coronary artery disease risk and C-reactive protein levels. Am J Cardiol 85:140-146, 2000
35. ESPINOLA-KLEIN C, RUPPRECHT HJ, BLANKENBERG S, et al: Impact of infectious burden on progression of carotid atherosclerosis. Stroke 33:2581-2586, 2002
36. ESPINOLA-KLEIN C, RUPPRECHT HJ, BLANKENBERG S, et al: Impact of infectious burden on extent and long-term prognosis of atherosclerosis. Circulation 105:15-21, 2002
37. SMIEJA M, GNARPE J, LONN E, et al: Multiple infections and subsequent cardiovascular events in the Heart Outcomes Prevention Evaluation (HOPE) Study. Circulation 107:251-7, 2003
38. ZHU J, NIETO FJ, HORNE BD, et al: Prospective study of pathogen burden and risk of myocardial infarction or death. Circulation 103:45-51, 2001
39. YEUN JY, LEVINE RA, MANTADILOK V, KAYSEN GA: C-Reactive protein predicts all-cause and cardiovascular mortality in hemodialysis patients. Am J Kidney Dis 35:469-476, 2000
40. LOK CE, STANLEY KE, HUX JE, et al: Hemodialysis infection prevention with polysporin ointment. J Am Soc Nephrol 14:169-179, 2003
41. LOCATELLI FF, MANZONI C: Treatment modalities in comparison: When do clinical differences emerge? Nephrol Dial Transplant 15 (Suppl 1):29-35, 2000
42. STENVINKEL P: Inflammatory and atherosclerotic interactions in the depleted uremic patient. Blood Purif 19:53-61, 2001
43. RAYNER HC, PISONI RL, GILLESPIE BW, et al: Creation, cannulation and survival of arteriovenous fistulae: Data from the Dialysis Outcomes and Practice Patterns Study. Kidney Int 63:323-330, 2003
44. OLLENDORF DA, FENDRICK AM, MASSEY K, et al: Is sepsis accurately coded on hospital bills? Value Health 5:79-81, 2002
45. ROMANO PS, CHAN BK, SCHEMBRI ME, RAINWATER JA: Can administrative data be used to compare postoperative complication rates across hospitals? Med Care 40:856-867, 2002
46. ALLON M, DEPNER TA, RADEVA M, et al: Impact of dialysis dose and membrane on infection-related hospitalization and death: Results of the HEMO Study. J Am Sac Nephrol 14:1863-1870, 2003
47. JOHNSON DW, MACGINLEY R, KAY TD, et al: A randomized controlled trial of topical exit site mupirocin application in patients with tunnelled, cuffed haemodialysis catheters. Nephrol Dial Transplant 17:1802-1807, 2002
48. SHINEfiELD H, BLACK S, FATTOM A, et al: Use of a Staphylococcus aureus conjugate vaccine in patients receiving hemodialysis. N Engl J Med 346:491-496, 2002
49. LOK CE, STANLEY KE, HUX JE, et al: Hemodialysis infection prevention with polysporin ointment. J Am Soc Nephrol 14:169-179, 2003